Eric Ostertag - Net Worth and Insider Trading

Eric Ostertag Net Worth

The estimated net worth of Eric Ostertag is at least $20 Million dollars as of 2024-04-23. Eric Ostertag is the Executive Chairman, 10% Owner of Poseida Therapeutics Inc and owns about 9,398,519 shares of Poseida Therapeutics Inc (PSTX) stock worth over $20 Million. Details can be seen in Eric Ostertag's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Ostertag has not made any transactions after 2022-08-08 and currently still holds the listed stock(s).

Transaction Summary of Eric Ostertag

To

Eric Ostertag Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Ostertag owns 1 companies in total, including Poseida Therapeutics Inc (PSTX) .

Click here to see the complete history of Eric Ostertag’s form 4 insider trades.

Insider Ownership Summary of Eric Ostertag

Ticker Comapny Transaction Date Type of Owner
PSTX Poseida Therapeutics Inc 2022-08-08 director & 10 percent owner & Chief Executive Officer

Eric Ostertag Latest Holdings Summary

Eric Ostertag currently owns a total of 1 stock. Eric Ostertag owns 9,398,519 shares of Poseida Therapeutics Inc (PSTX) as of August 8, 2022, with a value of $20 Million.

Latest Holdings of Eric Ostertag

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PSTX Poseida Therapeutics Inc 2022-08-08 9,398,519 2.15 20,206,816

Holding Weightings of Eric Ostertag


Eric Ostertag Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Ostertag has made a total of 14 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 1 buys and 13 sells. The most-recent trade in Poseida Therapeutics Inc is the acquisition of 142,857 shares on August 8, 2022, which cost Eric Ostertag around $500,000.

Insider Trading History of Eric Ostertag

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Ostertag Trading Performance

GuruFocus tracks the stock performance after each of Eric Ostertag's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Ostertag is 21.08%. GuruFocus also compares Eric Ostertag's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Ostertag within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Ostertag's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Ostertag

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.32 21.08 127.57 -46.49
Relative Return to S&P 500(%) 7.55 28.61 128.11 -55.17

Eric Ostertag Ownership Network

Ownership Network List of Eric Ostertag

No Data

Ownership Network Relation of Eric Ostertag


Eric Ostertag Owned Company Details

What does Poseida Therapeutics Inc do?

Who are the key executives at Poseida Therapeutics Inc?

Eric Ostertag is the director & 10 percent owner & Chief Executive Officer of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and Chief Operating Officer Kerry D. Ingalls .

Poseida Therapeutics Inc (PSTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Poseida Therapeutics Inc Insider Transactions

No Available Data

Eric Ostertag Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Ostertag. You might contact Eric Ostertag via mailing address: C/o Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego Ca 92121.

Discussions on Eric Ostertag

No discussions yet.